Titan Pharmaceuticals, Inc. Debt Conversion, Converted Instrument, Amount
Titan Pharmaceuticals, Inc. reported Debt Conversion, Converted Instrument, Amount of $650.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2021-03-31
- Titan Pharmaceuticals, Inc. debt conversion, converted instrument, amount for the quarter ending 2019-06-30 was $650.00K.
- Titan Pharmaceuticals, Inc. debt conversion, converted instrument, amount for fiscal 2019 was $650.00K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|
| 2019-12-31 | $650.00K 10-K · filed 2021-03-31 | |
| 2019-06-30 | $650.00K 10-Q · filed 2020-11-16 |